Valuation: Fusen Pharmaceutical Company Limited

Market Cap 529M 622M 79.22M 70.51M 65.35M 59.22M 111M 7.5B 113M 784M 308M 3.93B 297M 291M 12.53B P/E 2024
-2.95x
P/E 2025 -45.1x
Enterprise Value 751M 883M 112M 100M 92.77M 84.06M 158M 10.65B 161M 1.11B 437M 5.57B 422M 413M 17.78B EV / Sales 2024
2.83x
EV / Sales 2025 2.76x
Free-Float
26.11%
Yield 2024 *
-
Yield 2025 -
1 day-2.89%
1 week-11.58%
Current month-6.67%
1 month+1.20%
3 months-18.45%
6 months-31.15%
Current year+5.00%
1 week 0.76
Extreme 0.765
0.93
1 month 0.72
Extreme 0.72
1.05
Current year 0.67
Extreme 0.67
1.44
1 year 0.64
Extreme 0.64
1.44
3 years 0.24
Extreme 0.235
1.75
5 years 0.24
Extreme 0.235
2.74
10 years 0.24
Extreme 0.235
20
Manager TitleAgeSince
Director of Finance/CFO 48 18/04/2019
Investor Relations Contact 40 18/01/2013
Corporate Secretary 36 30/09/2024
Director TitleAgeSince
Director/Board Member 63 07/04/2017
Director/Board Member 64 07/04/2017
Director/Board Member 61 07/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
19/4/24 Other

Chairman

650,000 0.0867%
18/4/24 Other

Chairman

240,000 0.0320%
18/4/24 Other

Chairman

240,000 0.0320%
Change 5-day change 1-year change 3-year change Capi.($)
-2.89%-11.58%+15.07%-44.00% 81.48M
+4.25%+11.04%+60.13%+121.56% 1,106B
+2.12%+4.13%+33.64%+69.21% 612B
+2.26%+5.38%+24.59%+97.72% 500B
+2.58%+8.37%+38.71%+63.14% 367B
+2.99%+4.33%+71.61%+44.28% 354B
+1.85%+6.04%+21.47%+49.17% 286B
+1.76%+6.07%+0.43%+20.98% 256B
+2.33%+5.21%+43.19%+55.79% 230B
+1.44%+5.06%+26.23%+99.74% 190B
Average +1.82%+0.44%+33.51%+57.76% 390.02B
Weighted average by Cap. +2.77%+2.30%+41.04%+80.92%

Financials

2024 2025
Net sales 326M 383M 48.81M 43.44M 40.26M 36.49M 68.57M 4.62B 69.72M 483M 190M 2.42B 183M 179M 7.72B 273M 321M 40.92M 36.43M 33.76M 30.59M 57.49M 3.88B 58.46M 405M 159M 2.03B 154M 150M 6.47B
Net income -189M -222M -28.26M -25.16M -23.31M -21.13M -39.7M -2.68B -40.37M -280M -110M -1.4B -106M -104M -4.47B -11.78M -13.85M -1.76M -1.57M -1.46M -1.32M -2.48M -167M -2.52M -17.46M -6.86M -87.46M -6.62M -6.48M -279M
Net Debt 367M 431M 54.98M 48.94M 45.35M 41.1M 77.24M 5.21B 78.53M 544M 214M 2.73B 206M 202M 8.69B 222M 261M 33.23M 29.58M 27.42M 24.84M 46.69M 3.15B 47.47M 329M 129M 1.65B 125M 122M 5.26B
Projected Income Statement - Annual - Fusen Pharmaceutical Company Limited
Logo Fusen Pharmaceutical Company Limited
Fusen Pharmaceutical Co Ltd is a company mainly engaged in the cultivation of Chinese herbal medicine, pharmaceutical research and development, and sales. The Company's main business is the sales of Shuanghuanglian Oral Solutions, Shuanghuanglian Injections and other pharmaceutical products. The Company is also engaged in the research, production, and sales of various proprietary Chinese medicine and western medicine products for treating cold, fever, cardiovascular diseases and anemia. The Company mainly conducts business in the domestic market.
Employees
817
Date Price Change Volume
20/10/26 HK$0.8400 -2.89% 49,000
16/10/26 HK$0.8650 0.00% 0
15/10/26 HK$0.8650 -6.99% 23,000
14/10/26 HK$0.9300 0.00% 1,000
13/10/26 HK$0.9300 -2.11% 31,000
  1. Stock Market
  2. Stocks
  3. 1652 Stock